Elyxium Wealth’s Haemonetics HAE Stock Holding History

Elyxium Wealth’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.53K	Buy	+24	New	+$2.23K	﹤0.01%	1286

Other funds holding HAE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return

VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Elyxium Wealth's HAE Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Haemonetics (HAE) in Q3 2026: 24 shares worth $2.53K. The stake represents ﹤0.01% of the portfolio and ranks #1286 among its holdings.

64 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

Elyxium Wealth held 24 shares of Haemonetics worth $2.53K as of Q3 2026.
Haemonetics was a new Elyxium Wealth position in Q3 2026.
Haemonetics made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1286 holding.
64 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.